|  |   | 
		| (2 intermediate revisions not shown.) | 
| Line 1: | Line 1: | 
|  | + |  | 
|  | ==The Solution Structure of the Magnesium-bound Conantokin-G Mutant== |  | ==The Solution Structure of the Magnesium-bound Conantokin-G Mutant== | 
| - | <StructureSection load='2mzl' size='340' side='right' caption='[[2mzl]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''> | + | <StructureSection load='2mzl' size='340' side='right'caption='[[2mzl]]' scene=''> | 
|  | == Structural highlights == |  | == Structural highlights == | 
| - | <table><tr><td colspan='2'>[[2mzl]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MZL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2MZL FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[2mzl]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Conus_rolani Conus rolani]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MZL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2MZL FirstGlance]. <br> | 
| - | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CGU:GAMMA-CARBOXY-GLUTAMIC+ACID'>CGU</scene>, <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CGU:GAMMA-CARBOXY-GLUTAMIC+ACID'>CGU</scene>, <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | 
| - | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2myz|2myz]], [[2mzk|2mzk]], [[2mzm|2mzm]]</td></tr>
 | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2mzl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mzl OCA], [https://pdbe.org/2mzl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2mzl RCSB], [https://www.ebi.ac.uk/pdbsum/2mzl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2mzl ProSAT]</span></td></tr> | 
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2mzl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mzl OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2mzl RCSB], [http://www.ebi.ac.uk/pdbsum/2mzl PDBsum]</span></td></tr> | + |  | 
|  | </table> |  | </table> | 
|  | + | == Function == | 
|  | + | [https://www.uniprot.org/uniprot/CKR1B_CONRO CKR1B_CONRO]  | 
|  | <div style="background-color:#fffaf0;"> |  | <div style="background-color:#fffaf0;"> | 
|  | == Publication Abstract from PubMed == |  | == Publication Abstract from PubMed == | 
| Line 15: | Line 17: | 
|  | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |  | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | 
|  | </div> |  | </div> | 
|  | + | <div class="pdbe-citations 2mzl" style="background-color:#fffaf0;"></div> | 
|  | == References == |  | == References == | 
|  | <references/> |  | <references/> | 
|  | __TOC__ |  | __TOC__ | 
|  | </StructureSection> |  | </StructureSection> | 
| - | [[Category: Balsara, R D]] | + | [[Category: Conus rolani]] | 
| - | [[Category: Castellino, F J]] | + | [[Category: Large Structures]] | 
| - | [[Category: Kunda, S]] | + | [[Category: Balsara RD]] | 
| - | [[Category: Yuan, Y]] | + | [[Category: Castellino FJ]] | 
| - | [[Category: Zajicek, J]] | + | [[Category: Kunda S]] | 
| - | [[Category: Hyp-containing]] | + | [[Category: Yuan Y]] | 
| - | [[Category: Metal binding protein]] | + | [[Category: Zajicek J]] | 
| - | [[Category: Nmdar antagonist]]
 | + |  | 
| - | [[Category: Toxin]]
 | + |  | 
| - | [[Category: Transport protein inhibitor]]
 | + |  | 
|  |   Structural highlights   Function CKR1B_CONRO 
 
  Publication Abstract from PubMed Conantokins are ~20 amino acid peptides present in predatory marine snail venoms that function as allosteric antagonists of ion channels of the N-methyl-D-aspartate receptor (NMDAR). These peptides possess a high percentage of post-/co-translationally modified amino acids, particularly gamma-carboxyglutamate (Gla). Appropriately spaced Gla residues allow binding of functional divalent cations, which induces end-to-end alpha-helices in many conantokins. A smaller number of these peptides additionally contain 4-hydroxyproline (HyP). HyP should prevent adoption of the metal ion-induced full alpha-helix, with unknown functional consequences. To address this disparity, as well as the role of HyP in conantokins, we have solved the high-resolution 3D-solution structure of a Gla/HyP-containing 18-residue conantokin, conRl-B, by high-field NMR spectroscopy. We show that HyP10 disrupts only a small region of the alpha-helix of the Mg2+/peptide complex, which displays cation-induced alpha-helices on each terminus of the peptide. The function of conRl-B was examined by measuring its inhibition of NMDA/Gly-mediated current through NMDAR ion channels in mouse cortical neurons. ConRl-B displays high inhibitory selectivity for subclasses of NMDARs that contain the functionally important GluN2B subunit. Replacement of HyP10 with N8Q results in a Mg2+-complexed end-to-end alpha-helix, accompanied by attenuation of NMDAR inhibitory activity. However, replacement of HyP10 with Pro10 allowed the resulting peptide to retain its inhibitory property, but diminished its GluN2B-specificity. Thus, these modified amino acids, in specific peptide backbones, play critical roles in their subunit-selective inhibition of NMDAR ion channels, a finding that can be employed to design NMDAR antagonists that function at ion channels of distinct NMDAR subclasses.
 Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities Toward Ion Channels of NMDA Receptors.,Kunda S, Yuan Y, Balsara RD, Zaijcek J, Castellino FJ J Biol Chem. 2015 Jun 5. pii: jbc.M115.650341. PMID:26048991[1]
 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
   References ↑ Kunda S, Yuan Y, Balsara RD, Zaijcek J, Castellino FJ. Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities Toward Ion Channels of NMDA Receptors. J Biol Chem. 2015 Jun 5. pii: jbc.M115.650341. PMID:26048991 doi:http://dx.doi.org/10.1074/jbc.M115.650341
 
 |